Watch the Webinar
Please provide your details to gain access.
The Cell and Gene Therapy Catapult takes your data very seriously. By using this form you are consenting to the processing of your personal data as per ourprivacy policy.
In this recording, Dr Stephen Ward, Chief Technology Officer at the Cell and Gene Therapy Catapult, presents his keynote address from ELRIG Cell & Gene Therapy 2026.
In this presentation, Dr Ward shares his perspective on three key areas: how cell and gene therapies are moving from promise to reality, the remaining barriers to realising the sector’s full potential, and the opportunities for collaboration to overcome these challenges and scale advanced therapies for more patients.
The presentation includes:
- Discussion of the critical drivers required for the cell and gene therapy industry to progress, covering new therapeutics, cost of goods, manufacturing at scale and high uptake by healthcare systems [00:13:19]
- Insights into how digitalisation, automation, and robotics can help accelerate advanced therapy development and manufacturing [00:21:18]
- Real-world examples of how CGT Catapult is supporting the UK and the global sector through collaboration to tackle hurdles and enact real change [throughout the recording]
